Skip to main content

Publications

What type of publication do you want to show?

2024

Metastatic pancreatic cancer: a new standardised dose-reduction regimen?

Ghaneh, P., & Palmer, D. (2024). Metastatic pancreatic cancer: a new standardised dose-reduction regimen?. The lancet. Gastroenterology & hepatology, 9(10), 898-900. doi:10.1016/s2468-1253(24)00227-9

DOI
10.1016/s2468-1253(24)00227-9
Journal article

2023

Adjuvant Chemotherapy in Pancreatic Cancer

Mann, K., Jones, R. P., Ghaneh, P., & Neoptolemos, J. P. (2023). Adjuvant Chemotherapy in Pancreatic Cancer. In Unknown Book (pp. 1143-1152). Wiley. doi:10.1002/9781119876007.ch148

DOI
10.1002/9781119876007.ch148
Chapter

Adjuvant and Palliative Chemotherapy of Periampullary Cancers

Ponweera, A. D. N. R., Ghaneh, P., & Neoptolemos, J. P. (2023). Adjuvant and Palliative Chemotherapy of Periampullary Cancers. In Unknown Book (pp. 1291-1298). Wiley. doi:10.1002/9781119876007.ch164

DOI
10.1002/9781119876007.ch164
Chapter

ESPAC-5 and future directions

Ghaneh, P. (2023). ESPAC-5 and future directions. Pancreatology, 23(4), e3-e4. doi:10.1016/j.pan.2023.04.017

DOI
10.1016/j.pan.2023.04.017
Journal article

Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) A Systematic Review and Delphi Consensus Statement

Pijnappel, E. N., Suurmeijer, J. A., Koerkamp, B. G., Kos, M., Siveke, J. T., Salvia, R., . . . van Laarhoven, H. W. M. (2023). Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB) A Systematic Review and Delphi Consensus Statement. JAMA ONCOLOGY, 8(6), 929-937. doi:10.1001/jamaoncol.2022.0168

DOI
10.1001/jamaoncol.2022.0168
Journal article

GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma

de Andres, M. P., Jackson, R. J., Felipe, I., Zagorac, S., Pilarsky, C., Schlitter, A. M., . . . Real, F. X. (2023). GATA4 and GATA6 loss-of-expression is associated with extinction of the classical programme and poor outcome in pancreatic ductal adenocarcinoma. GUT, 72(3), 535-548. doi:10.1136/gutjnl-2021-325803

DOI
10.1136/gutjnl-2021-325803
Journal article

2022

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.

Ghaneh, P., Palmer, D., Cicconi, S., Jackson, R., Halloran, C. M., Rawcliffe, C., . . . European Study Group for Pancreatic Cancer. (2022). Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.. The lancet. Gastroenterology & hepatology, S2468-1253(22)00348-X. doi:10.1016/s2468-1253(22)00348-x

DOI
10.1016/s2468-1253(22)00348-x
Journal article

Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer

Ponweera, A., Robinson, M., Jackson, R., Halloran, C., Palmer, D., Hackert, T., . . . Ghaneh, P. (2022). Evaluation of the prognostic role of aspirin and metformin in the ESPAC 4 randomised trial of adjuvant gemcitabine versus gemcitabine plus capecitabine in patients with resected pancreatic cancer. In BRITISH JOURNAL OF SURGERY Vol. 109. doi:10.1093/bjs/znac404.107

DOI
10.1093/bjs/znac404.107
Conference Paper

United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer

Oldfield, L., Stott, M., Hanson, R., Jackson, R. J., Reynolds, W., Chandran-Gorner, V., . . . Costello, E. (2022). United Kingdom Early Detection Initiative (UK-EDI): protocol for establishing a national multicentre cohort of individuals with new-onset diabetes for early detection of pancreatic cancer. BMJ OPEN, 12(10). doi:10.1136/bmjopen-2022-068010

DOI
10.1136/bmjopen-2022-068010
Journal article

A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.

Halloran, C. M., Neoptolemos, J. P., Jackson, R., Platt, K., Psarelli, E. -E., Reddy, S., . . . Ghaneh, P. (2022). A Multicenter, Randomized, Double-Blinded, Clinical Trial Comparing Cattell-Warren and Blumgart Anastomoses Following Partial Pancreatoduodenectomy: PANasta Trial.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 3(3), e198. doi:10.1097/as9.0000000000000198

DOI
10.1097/as9.0000000000000198
Journal article

Pre-surgical staging and surveillance after curative treatment for pancreatic ductal adenocarcinoma (PDAC): Survey of practice in the United Kingdom (UK)

Lamarca, A., Roberts, K., Graham, J., Kocher, H., Chang, D., Ghaneh, P., . . . Valle, J. (2022). Pre-surgical staging and surveillance after curative treatment for pancreatic ductal adenocarcinoma (PDAC): Survey of practice in the United Kingdom (UK). In ANNALS OF ONCOLOGY Vol. 33 (pp. S278-S279). doi:10.1016/j.annonc.2022.04.175

DOI
10.1016/j.annonc.2022.04.175
Conference Paper

Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial

Rai, Z. L., Ranieri, V., Palmer, D. H., Littler, P., Ghaneh, P., Gurusamy, K., . . . Davidson, B. R. (2022). Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial. BMJ OPEN, 12(5). doi:10.1136/bmjopen-2021-050166

DOI
10.1136/bmjopen-2021-050166
Journal article

Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study.

de Rijk, F. E. M., van Veldhuisen, C. L., Besselink, M. G., van Hooft, J. E., van Santvoort, H. C., van Geenen, E. J. M., . . . Dutch Pancreatitis Study Group. (2022). Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22(4), 457-465. doi:10.1016/j.pan.2022.03.013

DOI
10.1016/j.pan.2022.03.013
Journal article

Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes

Oldfield, L., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T., Psarelli, E. E., . . . Costello, E. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBIOMEDICINE, 75. doi:10.1016/j.ebiom.2021.103802

DOI
10.1016/j.ebiom.2021.103802
Journal article

2021

Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach

Radhakrishna, G., & Ghaneh, P. (2021). Optimising treatment pathways for borderline and locally advanced pancreatic cancer: an adaptive personalised approach. BRITISH JOURNAL OF CANCER, 125(9), 1179-1180. doi:10.1038/s41416-021-01416-8

DOI
10.1038/s41416-021-01416-8
Journal article

Concordance of human equilibrative nucleoside transporter‐1 expressions between murine ( 10D7G2 ) and rabbit ( SP120 ) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial

Okamura, Y., Boku, N., Ghaneh, P., Greenhalf, W., Yasukawa, S., Narimatsu, H., . . . Uesaka, K. (2021). Concordance of human equilibrative nucleoside transporter‐1 expressions between murine ( 10D7G2 ) and rabbit ( SP120 ) antibodies and association with clinical outcomes of adjuvant chemotherapy for pancreatic cancer: A collaborative study from the JASPAC 01 trial. Cancer Reports. doi:10.1002/cnr2.1507

DOI
10.1002/cnr2.1507
Journal article

Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic"

Jones, C. M., Radhakrishna, G., Aitken, K., Bridgewater, J., Corrie, P., Eatock, M., . . . Mukherjee, S. (2021). Reply to Comment on "The UK consensus position on the treatment of pancreatic cancer during the COVID-19 pandemic". BRITISH JOURNAL OF CANCER, 124(3), 679-680. doi:10.1038/s41416-020-01133-8

DOI
10.1038/s41416-020-01133-8
Journal article

Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials.

Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2021). Digital quantification of GATA6 expression from immunohistochemistry is associated with overall survival after surgery for pancreatic cancer in the ESPAC trials.. In CANCER RESEARCH Vol. 81. Retrieved from https://www.webofscience.com/

Conference Paper

Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections.

Saunders, R., Neoptolemos, J. P., Hughes, F., Ghaneh, P., & Halloran, C. M. (2021). Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections.. Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2(1), e019. doi:10.1097/as9.0000000000000019

DOI
10.1097/as9.0000000000000019
Journal article

Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report

Salvia, R., Marchegiani, G., Balduzzi, A., Pollini, T., Caravati, A., Maggino, L., . . . Zyromski, N. (2021). Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report. DIGESTIVE SURGERY, 38(4), 316-322. doi:10.1159/000518190

DOI
10.1159/000518190
Journal article

2020

An international pragmatic randomized controlled trial to compare a single-use negative-pressure dressing versus the surgeon's preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol

Wilkin, R., Coe, P., Duarte, R., Stott, M., Pockney, P., Egoroff, N., . . . Collaborative, W. M. R. (2021). An international pragmatic randomized controlled trial to compare a single-use negative-pressure dressing versus the surgeon's preference of dressing to reduce the incidence of surgical site infection following emergency laparotomy: the SUNRRISE trial protocol. COLORECTAL DISEASE, 23(4), 989-1000. doi:10.1111/codi.15474

DOI
10.1111/codi.15474
Journal article

GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials

Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2020). GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials. In CANCER RESEARCH Vol. 80. doi:10.1158/1538-7445.PANCA20-PO-005

DOI
10.1158/1538-7445.PANCA20-PO-005
Conference Paper

PANasta Trial: Cattell Warren Versus Blumgart Techniques of Pancreatico-Jejunostomy Following Pancreato-Duodenectomy - A Randomized Double Blind Multi-Center Trial

Halloran, C. M., Neoptolemos, J. P., Jackson, R., Reddy, S., Gomez, D., O'Reilly, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren Versus Blumgart Techniques of Pancreatico-Jejunostomy Following Pancreato-Duodenectomy - A Randomized Double Blind Multi-Center Trial. In PANCREAS Vol. 49 (pp. 1411). Retrieved from https://www.webofscience.com/

Conference Paper

PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.

Halloran, C., Neoptolemos, J. P., Platt, K., Jackson, R., Reddy, S., Oreily, D., . . . Ghaneh, P. (2020). PANasta Trial: Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy-A double-blinded multi-centered trial, trial results.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/

Conference Paper

Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS)

Miao, Y., Lu, Z., Yeo, C. J., Vollmer, C. M. J., Fernandez-del Castillo, C., Ghaneh, P., . . . Buchler, M. W. (2020). Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). SURGERY, 168(1), 72-84. doi:10.1016/j.surg.2020.02.018

DOI
10.1016/j.surg.2020.02.018
Journal article

ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.

Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Valle, J. W., Cunningham, D., Wadsley, J., . . . Buchler, M. W. (2020). ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma: Five year follow-up.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 38. Retrieved from https://www.webofscience.com/

Conference Paper

ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer

Ghaneh, P., Palmer, D., Cicconi, S., Halloran, C. M., Jackson, R., Rawcliffe, C., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer. In PANCREAS Vol. 49 (pp. 1410). Retrieved from https://www.webofscience.com/

Conference Paper

GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials.

Grant, R. C., Duan, K., Jackson, R., Greenhalf, W., Costello-Goldring, E., Ghaneh, P., . . . Fischer, S. (2020). GATA6 expression is prognostic after surgical resection of pancreatic cancer: results from the ESPAC trials.. In CANCER RESEARCH Vol. 80. Retrieved from https://www.webofscience.com/

Conference Paper

2019

Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS

Neoptolemos, J. P., Ghaneh, P., Kleeff, J., Halloran, C. M., & Büchler, M. W. (2019). Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS. ANNALS OF SURGERY, 270(06), E130-E131. doi:10.1097/SLA.0000000000003371

DOI
10.1097/SLA.0000000000003371
Journal article

The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis

Sheel, A. R. G., Baron, R. D., Dickerson, L. D., Ghaneh, P., Campbell, F., Raraty, M. G. T., . . . Neoptolemos, J. P. (2019). The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 404(7), 831-840. doi:10.1007/s00423-019-01837-3

DOI
10.1007/s00423-019-01837-3
Journal article

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Jones, R. P., Psarelli, E. -E., Jackson, R., Ghaneh, P., Halloran, C. M., Palmer, D. H., . . . Millat, B. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154(11), 1038-1048. doi:10.1001/jamasurg.2019.3337

DOI
10.1001/jamasurg.2019.3337
Journal article

A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous

Saunders, R., Ramesh, J., Cicconi, S., Evans, J., Yip, V. S., Raraty, M., . . . Halloran, C. (2019). A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 33(5), 1412-1425. doi:10.1007/s00464-018-6416-5

DOI
10.1007/s00464-018-6416-5
Journal article

Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma

Mann, K., Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2019). Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404(4), 439-449. doi:10.1007/s00423-019-01779-w

DOI
10.1007/s00423-019-01779-w
Journal article

The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Ghaneh, P., Kleeff, J., Halloran, C. M., Raraty, M., Jackson, R., Melling, J., . . . Smith, C. (2019). The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 269(03), 520-529. doi:10.1097/SLA.0000000000002557

DOI
10.1097/SLA.0000000000002557
Journal article

Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging

Dickerson, L. D., Farooq, A., Bano, F., Kleeff, J., Baron, R., Raraty, M., . . . Yip, V. S. (2019). Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging. WORLD JOURNAL OF SURGERY, 43(6), 1604-1611. doi:10.1007/s00268-019-04928-w

DOI
10.1007/s00268-019-04928-w
Journal article

A multicentre investigation into the management and outcome of patients treated for Pyogenic Liver Abscess

Gilbert, T., Sheel, A., Fretwell, V., Ghaneh, P., Halloran, C., & Mann, K. (2019). A multicentre investigation into the management and outcome of patients treated for Pyogenic Liver Abscess. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 29). Retrieved from https://www.webofscience.com/

Conference Paper

An Independent Patient Data Meta Analysis to compare adjuvant therapies in patients suffering with Pancreatic Cancer

Griffin, R., Psarelli, E. -E., Ghaneh, P., Neoptolemos, J., & Jackson, R. (2019). An Independent Patient Data Meta Analysis to compare adjuvant therapies in patients suffering with Pancreatic Cancer. In TRIALS Vol. 20. Retrieved from https://www.webofscience.com/

Conference Paper

Early specialist opinion may reduce the use of percutaneous cholecystostomy for cholecystitis - a collaborative regional study

Mann, K., Dickerson, L., Fretwell, V., Sheel, A., Ghaneh, P., & Halloran, C. (2019). Early specialist opinion may reduce the use of percutaneous cholecystostomy for cholecystitis - a collaborative regional study. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 10-11). Retrieved from https://www.webofscience.com/

Conference Paper

Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.

Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., . . . Greenhalf, W. (2019). Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.. The American Journal of Gastroenterology (Elsevier), 114(1), 155-164. doi:10.1038/s41395-018-0395-y

DOI
10.1038/s41395-018-0395-y
Journal article

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Neoptolemos, J. P., Jones, R. P., Psarelli, E. E., Jackson, R., Ghaneh, P., Halloran, C. M., . . . Buechler, M. W. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. In PANCREAS Vol. 48 (pp. 1497-1498). Retrieved from https://www.webofscience.com/

Conference Paper

Pre-operative anaemia increases length of stay and transfusion requirements in patients undergoing major pancreatic resection

Dickerson, L., Downey, R., Cawley, A., Dunne, D., Szatmary, P., Ghaneh, P., . . . Baron, R. (2019). Pre-operative anaemia increases length of stay and transfusion requirements in patients undergoing major pancreatic resection. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 17-18). Retrieved from https://www.webofscience.com/

Conference Paper

The evolution and development of an acute pancreatitis tertiary centre

Taylor, L., Saunders, R., McCready, R., Hughes, F., Raraty, M., Baron, R., . . . Halloran, C. (2019). The evolution and development of an acute pancreatitis tertiary centre. In BRITISH JOURNAL OF SURGERY Vol. 106 (pp. 18). Retrieved from https://www.webofscience.com/

Conference Paper

hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer

Hale, J., Evans, A., Aughton, K., Elander, N. O., Ghaneh, P., Neoptolemos, J. P., . . . Greenhalf, W. (2019). hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer. In PANCREAS Vol. 48 (pp. 1436-1437). Retrieved from https://www.webofscience.com/

Conference Paper

2018

The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis

Sheel, A. R. G., Baron, R. D., Sarantitis, I., Ramesh, J., Ghaneh, P., Raraty, M. G. T., . . . Neoptolemos, J. P. (2018). The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis. PANCREATOLOGY, 18(7), 774-784. doi:10.1016/j.pan.2018.08.002

DOI
10.1016/j.pan.2018.08.002
Journal article

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy

Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., . . . Canc, E. S. G. P. (2018). Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118, 1084-1088. doi:10.1038/s41416-018-0005-1

DOI
10.1038/s41416-018-0005-1
Journal article

Adjuvant Chemotherapy in Pancreatic Cancer

Neoptolemos, J. P., Cunningham, D., Sclafani, F., & Ghaneh, P. (2018). Adjuvant Chemotherapy in Pancreatic Cancer. In Pancreatic Cancer (pp. 1039-1071). Springer New York. doi:10.1007/978-1-4939-7193-0_43

DOI
10.1007/978-1-4939-7193-0_43
Chapter

Arterial Resection in Pancreatic Cancer

Dunne, D. F. J., Kleeff, J., Yip, V. S., Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2018). Arterial Resection in Pancreatic Cancer. In Pancreatic Cancer (pp. 1089-1104). Springer New York. doi:10.1007/978-1-4939-7193-0_72

DOI
10.1007/978-1-4939-7193-0_72
Chapter

Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial

Halloran, C. M. (2018). Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial. Annals of Surgery, 267(2), 364-369. doi:10.1097/SLA.0000000000002088

DOI
10.1097/SLA.0000000000002088
Journal article

PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer

Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd-Williams, H., . . . Neoptolemos, J. P. (2018). PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality <SUP>18</SUP>fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. HEALTH TECHNOLOGY ASSESSMENT, 22(7), 1-+. doi:10.3310/hta22070

DOI
10.3310/hta22070
Journal article

2017

The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies

Rao, R. G., Costello, E., Halloran, C. M., Oldfield, L., Greenhalf, W., Ghaneh, P., . . . Mann, K. (2017). The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies. In PANCREAS Vol. 46 (pp. 1403-1404). Retrieved from https://www.webofscience.com/

Conference Paper

COST-EFFECTIVENESS OF PET/CT IN PRE-OPERATIVE STAGING OF PANCREATIC CANCER: AN ECONOMIC EVALUATION OF THE PET-PANC COHORT STUDY

Plumpton, C. O., Ghaneh, P., Lloyd-Williams, H., Yeo, S. T., & Edwards, R. T. (2017). COST-EFFECTIVENESS OF PET/CT IN PRE-OPERATIVE STAGING OF PANCREATIC CANCER: AN ECONOMIC EVALUATION OF THE PET-PANC COHORT STUDY. In VALUE IN HEALTH Vol. 20 (pp. A589). doi:10.1016/j.jval.2017.08.1078

DOI
10.1016/j.jval.2017.08.1078
Conference Paper

USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES

Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). USAGE OF TRANSMURAL METAL STENTS FOR ENDOSCOPIC ULTRASOUND GUIDED DRAINAGE OF PSEUDOCYSTS MAY LEAD TO LOWER REINTERVENTION RATES. In GUT Vol. 66 (pp. A276). doi:10.1136/gutjnl-2017-314472.538

DOI
10.1136/gutjnl-2017-314472.538
Conference Paper

Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.

Neoptolemos, J. P., Palmer, D., Greenhalf, W., Ghaneh, P., Jackson, R., Evans, A., . . . Middleton, G. W. (2017). Biomarker prediction of efficacy to vandetanib plus gemcitabine in a phase II double blind multicenter randomized placebo controlled trial in locally advanced or metastatic pancreatic carcinoma.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 35. doi:10.1200/JCO.2017.35.15_suppl.4104

DOI
10.1200/JCO.2017.35.15_suppl.4104
Conference Paper

Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial

Middleton, G., Palmer, D. H., Greenhalf, W., Ghaneh, P., Jackson, R., Cox, T., . . . Neoptolemos, J. P. (2017). Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. The Lancet Oncology, 18(4), 486-499. doi:10.1016/S1470-2045(17)30084-0

DOI
10.1016/S1470-2045(17)30084-0
Journal article

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.

Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., . . . Büchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.. Lancet (London, England), 389(10073), 1011-1024. doi:10.1016/s0140-6736(16)32409-6

DOI
10.1016/s0140-6736(16)32409-6
Journal article

Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy

Bird, N. T. E., Elmasry, M., Jones, R., Psarelli, E., Dodd, J., Malik, H., . . . Palmer, D. (2017). Immunohistochemical hENT1 expression as a prognostic biomarker in patients with resected pancreatic ductal adenocarcinoma undergoing adjuvant gemcitabine-based chemotherapy. BRITISH JOURNAL OF SURGERY, 104(4), 328-336. doi:10.1002/bjs.10482

DOI
10.1002/bjs.10482
Journal article

Internal pilot sample size re-estimation in paired comparative diagnostic accuracy trials with a binary response

McCray, G., Titman, A., Ghaneh, P., & Lancaster, G. (2017). Internal pilot sample size re-estimation in paired comparative diagnostic accuracy trials with a binary response. In TRIALS Vol. 18. Retrieved from https://www.webofscience.com/

Conference Paper

Pancreatic necrosis: patterns of microbiology culture results and antibiotics sensitivity

Mohamed, E., Wai, M., & Ghaneh, P. (2017). Pancreatic necrosis: patterns of microbiology culture results and antibiotics sensitivity. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 32). Retrieved from https://www.webofscience.com/

Conference Paper

Small pancreatic ductal adenocarcinoma: a true clinical entity or an invalid diagnostic myth

Mohamed, E., Dodd, J., & Ghaneh, P. (2017). Small pancreatic ductal adenocarcinoma: a true clinical entity or an invalid diagnostic myth. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 12-13). Retrieved from https://www.webofscience.com/

Conference Paper

Treatment of walled off pancreatic necrosis by indirect trannsluminal irrigation endoscopic necrosectomy

Ramesh, J., Saunders, R., Evans, J., Smart, H., McCready, R., Hughes, F., . . . Halloran, C. (2017). Treatment of walled off pancreatic necrosis by indirect trannsluminal irrigation endoscopic necrosectomy. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 18). Retrieved from https://www.webofscience.com/

Conference Paper

Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates

Ramesh, J., Saunders, R., Evans, J., Ghaneh, P., Raraty, M., Yip, V., . . . Halloran, C. (2017). Usage of transmural metal stents for endoscopic ultrasound guided drainage of pseudocysts may lead to lower reintervention rates. In BRITISH JOURNAL OF SURGERY Vol. 104 (pp. 27). Retrieved from https://www.webofscience.com/

Conference Paper

2016

ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma

Neoptolemos, J. P., Palmer, D., Ghaneh, P., Valle, J., Cunningham, D., Wadsley, J., . . . Buechler, M. W. (2016). ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma. In Pancreas Vol. 45 (pp. 1529). Boston: Wolters Kluwer Health. Retrieved from https://journals.lww.com/

Conference Paper

Misdiagnosis of Chronic Pancreatitis (CP) in a UK Regional Pancreas Center

Sheel, A. R. G., Halloran, C., Ghaneh, P., Baron, R. D., Raraty, M., Kleeff, J., . . . Neoptolemos, J. P. (2016). Misdiagnosis of Chronic Pancreatitis (CP) in a UK Regional Pancreas Center. In Pancreas Vol. 45 (pp. 1538). Boston: Wolters Kluwer Health. Retrieved from https://journals.lww.com/

Conference Paper

Objective assessment of trainee operative experience in a tertiary hepatobiliary unit

Joshi, H. M., Alabraba, E., Tufo, A., Zone, A., Ghaneh, P., Fenwick, S. W., . . . Malik, H. Z. (2016). Objective assessment of trainee operative experience in a tertiary hepatobiliary unit. EJSO, 42(10), 1548-1551. doi:10.1016/j.ejso.2016.07.139

DOI
10.1016/j.ejso.2016.07.139
Journal article

PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer

Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. doi:10.1200/JCO.2016.34.15_suppl.4008

DOI
10.1200/JCO.2016.34.15_suppl.4008
Conference Paper

PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.

Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.. In Journal of Clinical Oncology Vol. Vol 34. Chicago: American Society of Clinical Oncology.

Conference Paper

Pancreatic cancer

Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., . . . Neoptolemos, J. P. (2016). Pancreatic cancer. In Unknown Book (Vol. 2). doi:10.1038/nrdp.2016.22

DOI
10.1038/nrdp.2016.22
Chapter

A Personalized Approach to Adjuvant Therapy: Cytoplasmic HuR Status Predicts Disease Free Survival After Resection for Pancreatic Ductal Adenocarcinoma

Tatarian, T., Grigoli, A., Leiby, B. E., Jimbo, M., Dabbish, N., Jiang, W., . . . Brody, J. R. (2016). A Personalized Approach to Adjuvant Therapy: Cytoplasmic HuR Status Predicts Disease Free Survival After Resection for Pancreatic Ductal Adenocarcinoma. In GASTROENTEROLOGY Vol. 150 (pp. S1211). doi:10.1016/S0016-5085(16)34095-1

DOI
10.1016/S0016-5085(16)34095-1
Conference Paper

Preface

Khosmood, F., & Fowler, A. (2016). Preface. Proceedings of the International Conference on Game Jams, Hackathons, and Game Creation Events, GJH and GC 2016.

Journal article

PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial

Halloran, C. M., Platt, K., Gerard, A., Polydoros, F., O'Reilly, D. A., Gomez, D., . . . Ghaneh, P. (2016). PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial. TRIALS, 17. doi:10.1186/s13063-015-1144-9

DOI
10.1186/s13063-015-1144-9
Journal article

Changes in the Expression of RRM Subunits Induce Gemcitabine Resistance in a Growth Dependent Manner

Mann, K. S., Brumskill, S., Ghaneh, P., & Greenhalf, W. (2016). Changes in the Expression of RRM Subunits Induce Gemcitabine Resistance in a Growth Dependent Manner. PANCREAS, 45(10), 1523. Retrieved from https://www.webofscience.com/

Journal article

ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.

Neoptolemos, J. P., Palmer, D., Ghaneh, P., Valle, J. W., Cunningham, D., Wadsley, J., . . . Buchler, M. W. (2016). ESPAC-4: A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination chemotherapy of gemcitabine (GEM) and capecitabine (CAP) versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma.. In JOURNAL OF CLINICAL ONCOLOGY Vol. 34. Retrieved from https://www.webofscience.com/

Conference Paper

Pancreatic and ampullary cancer

Mann, K., Gilbert, T., Oldfield, F., & Ghaneh, P. (2016). Pancreatic and ampullary cancer. In Surgical Oncology: Theory and Multidisciplinary Practice, Second Edition (pp. 403-427).

Chapter

2015

Actinomycin D Sensitizes Chemotherapy Resistant Suit-2 Pancreatic Cancer Cell Lines to Gemcitabine

Mann, K., Rogoyski, B., Ghaneh, P., Rubbi, C., & Greenhalf, W. (2015). Actinomycin D Sensitizes Chemotherapy Resistant Suit-2 Pancreatic Cancer Cell Lines to Gemcitabine. Pancreas, 44(8), 1395-1396. Retrieved from https://journals.lww.com/

Journal article

Evidence of adjuvant chemotherapy of ductal pancreatic cancer

Sultana, A., Halloran, C., Palmer, D., Ghaneh, P., Cox, T., & Neoptolemos, J. P. (2015). Evidence of adjuvant chemotherapy of ductal pancreatic cancer. In PANCREATIC CANCER, CYSTIC NEOPLASMS, AND ENDOCRINE TUMORS: DIAGNOSIS AND MANAGEMENT (pp. 94-102). Retrieved from https://www.webofscience.com/

Chapter

Biomarkers for early diagnosis of pancreatic cancer

Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, B., . . . Costello-Goldring, E. (2015). Biomarkers for early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology, 9(03), 305-315. doi:10.1586/17474124.2015.965145

DOI
10.1586/17474124.2015.965145
Journal article

A Single p53 Mutation May Predict Survival in Intraductal Papillary Mucinous Neoplasms of the Pancreas

Nicholson, J., Howes, N., Harrison, S., Hanna, T., Yan, L., Lane, B., . . . Greenhalf, W. (2015). A Single p53 Mutation May Predict Survival in Intraductal Papillary Mucinous Neoplasms of the Pancreas. PANCREAS, 44(8), 1402. Retrieved from https://www.webofscience.com/

Journal article

Adjuvant Therapy in Pancreatic Cancer

Oldfield, F., Ghaneh, P., Jackson, R., & Halloran, C. (n.d.). Adjuvant Therapy in Pancreatic Cancer. International Journal of Digestive Diseases, 01(01). doi:10.4172/2472-1891.100003

DOI
10.4172/2472-1891.100003
Journal article

Cytidine Deaminase (CDA) Transcript Analysis Complements hENT1 Protein Staining in Predicting Gemcitabine Response in the ESPAC-3 Pancreatic Cancer Cohort

Elander, N., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Costello, E., Palmer, D., . . . Greenhalf, W. (2015). Cytidine Deaminase (CDA) Transcript Analysis Complements hENT1 Protein Staining in Predicting Gemcitabine Response in the ESPAC-3 Pancreatic Cancer Cohort. PANCREAS, 44(8), 1371. Retrieved from https://www.webofscience.com/

Journal article

Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.

Nicholson, J., Greenhalf, B., Jackson, R., Cox, T., Butler, J., Hanna, T., . . . Neoptolemos, J. (2015). Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.. Pancreas, 44(02), 260-265. doi:10.1097/MPA.0000000000000246

DOI
10.1097/MPA.0000000000000246
Journal article

2014

Adjuvant therapy in pancreatic cancer

Jones, O. P., Melling, J. D., & Ghaneh, P. (2014). Adjuvant therapy in pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(40), 14733-14746. doi:10.3748/wjg.v20.i40.14733

DOI
10.3748/wjg.v20.i40.14733
Journal article

Risk stratification, management and outcomes in emergency general surgical patients in the UK

Johnstone, M., Pennick, M., Gossedge, G., Oshin, O., Sutton, P., Dunne, D., . . . Vimalachandran, D. (2014). Risk stratification, management and outcomes in emergency general surgical patients in the UK. EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY, 40(5), 617-624. doi:10.1007/s00068-014-0399-2

DOI
10.1007/s00068-014-0399-2
Journal article

Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer

Sultana, A., Jackson, R. J., Cox, T., Palmer, D., Neoptolemos, J., & Ghaneh, P. (n.d.). Chemotherapy, radiotherapy, chemoradiotherapy and combination therapy in localised and locally advanced pancreatic cancer. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd011044

DOI
10.1002/14651858.cd011044
Journal article

Prognostic markers in acute pancreatitis

Gomatos, I. P., Xiaodong, X., Ghaneh, P., Halloran, C., Raraty, M., Lane, B., . . . Neoptolemos, J. P. (2014). Prognostic markers in acute pancreatitis. Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare, 14(3), 333-346. doi:10.1586/14737159.2014.897608

DOI
10.1586/14737159.2014.897608
Journal article

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.

Valle, J., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., . . . Büchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study.. Journal of Clinical Oncology, 32(6), 504-512. doi:10.1200/JCO.2013.50.7657

DOI
10.1200/JCO.2013.50.7657
Journal article

Adjuvant chemotherapy for rectal cancer

Thornton, M., & Rooney, P. S. (2014). Adjuvant chemotherapy for rectal cancer. In Unknown Book (Vol. 15, pp. e196). Elsevier BV. doi:10.1016/s1470-2045(14)70130-5

DOI
10.1016/s1470-2045(14)70130-5
Chapter

Combination Therapy With Gemcitabine and a Novel Plk1 Inhibitor Causes Caspase-Independent Cell Death in Pancreatic Cancer Cells

Jones, O. P., Greenhalf, W., Halloran, C., Neoptolemos, J. P., & Ghaneh, P. (2014). Combination Therapy With Gemcitabine and a Novel Plk1 Inhibitor Causes Caspase-Independent Cell Death in Pancreatic Cancer Cells. PANCREAS, 43(8), 1372. Retrieved from https://www.webofscience.com/

Journal article

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Bonnetain, F., Bonsing, B., Conroy, T., Dousseau, A., Glimelius, B., Haustermans, K., . . . Collette, L. (2014). Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials). European Journal of Cancer, 50(17), 2983-2993. doi:10.1016/j.ejca.2014.07.011

DOI
10.1016/j.ejca.2014.07.011
Journal article

Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis

Gomatos, I., Halloran, C., Raraty, M., Evans, J., Ghaneh, P., Smart, H., . . . Neoptolemos, J. (2014). Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis. PANCREAS, 43(8), 1360-1361. Retrieved from https://www.webofscience.com/

Journal article

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.

Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Lamb, R. F., . . . Büchler, M. W. (2014). Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.. Journal of the National Cancer Institute, 106(1). doi:10.1093/jnci/djt347

DOI
10.1093/jnci/djt347
Journal article

Risk of Other Cancers in Familial Pancreatic Cancer

Hanna, T., Nicholson, J., Harrison, S., Johnstone, M., Ghaneh, P., Sutton, R., . . . Greenhalf, W. (2014). Risk of Other Cancers in Familial Pancreatic Cancer. PANCREAS, 43(8), 1363. Retrieved from https://www.webofscience.com/

Journal article

Systematic review and meta-analyses of the diagnosis of Pancreatic Intraductal Papillary Mucinous Neoplasia (IPMN)

Sultana, A., Jackson, R., Ghaneh, P., Raraty, M., Sutton, R., Neoptolemos, J., & Halloran, C. (2014). Systematic review and meta-analyses of the diagnosis of Pancreatic Intraductal Papillary Mucinous Neoplasia (IPMN). In BRITISH JOURNAL OF SURGERY Vol. 101 (pp. 28). Retrieved from https://www.webofscience.com/

Conference Paper

The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection

Gomez, D., Wetherill, C., Cheong, J., Jones, L., Marshall, E., Damato, B., . . . Fenwick, S. W. (2014). The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection. JOURNAL OF SURGICAL ONCOLOGY, 109(6), 542-547. doi:10.1002/jso.23535

DOI
10.1002/jso.23535
Journal article

Use of Citrullinated Histones and Circulating Nucleosomes in Early Prediction of Organ Failure in Acute Pancreatitis

Szatmary, P., Liu, T., Huang, W., Wang, G., Latawiec, D., Davies, K., . . . Sutton, R. (2014). Use of Citrullinated Histones and Circulating Nucleosomes in Early Prediction of Organ Failure in Acute Pancreatitis. PANCREAS, 43(8), 1413. Retrieved from https://www.webofscience.com/

Journal article

2013

Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study

Jones, R. P., Sutton, P., Greensmith, R. M. D., Santoyo-Castelazo, A., Carr, D. F., Jenkins, R., . . . Kitteringham, N. R. (2013). Hepatic activation of irinotecan predicts tumour response in patients with colorectal liver metastases treated with DEBIRI: exploratory findings from a phase II study. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 72(2), 359-368. doi:10.1007/s00280-013-2199-5

DOI
10.1007/s00280-013-2199-5
Journal article

MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients

Marshall, E., Romaniuk, C., Ghaneh, P., Wong, H., McKay, M., Chopra, M., . . . Damato, B. E. (2013). MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. BRITISH JOURNAL OF OPHTHALMOLOGY, 97(2), 159-163. doi:10.1136/bjophthalmol-2012-302323

DOI
10.1136/bjophthalmol-2012-302323
Journal article

MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients

Marshall, E., Romaniuk, C., Ghaneh, P., Wong, H., McKay, M., Chopra, M., . . . Damato, B. E. (2013). MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients. British Journal of Ophthalmology, 97(2), 159-163. doi:10.1136/bjophthalmol-2012-302323

DOI
10.1136/bjophthalmol-2012-302323
Journal article

CA19-9 Is a Significant Prognostic Factor Following Pancreatoduodenectomy for Intra-Pancreatic Bile Duct Cancer (Cholangiocarcinoma)

Melling, J., Thomas, A., Sykes, P., Jones, O., Jackson, R., Whelan, P., . . . Ghaneh, P. (2013). CA19-9 Is a Significant Prognostic Factor Following Pancreatoduodenectomy for Intra-Pancreatic Bile Duct Cancer (Cholangiocarcinoma). In PANCREAS Vol. 42 (pp. 1367-1368). Retrieved from https://www.webofscience.com/

Conference Paper

Characteristics and Outcomes of Borderline Resectable Pancreatic Cancer Compared with Resectable Disease

Thomas, A., Melling, J., Jackson, R., Whelan, P., Sykes, P., Jones, O., . . . Ghaneh, P. (2013). Characteristics and Outcomes of Borderline Resectable Pancreatic Cancer Compared with Resectable Disease. In PANCREAS Vol. 42 (pp. 1386). Retrieved from https://www.webofscience.com/

Conference Paper

Consensus for definition of time-to-event endpoints in pancreatic

Bonnetain, F., Bonsing, B., & Ghaneh et al, P. (2013). Consensus for definition of time-to-event endpoints in pancreatic. Lancet Oncology.

Journal article

Development of a Novel Next Generation Sequencing (NGS) Method for Detection of Low Concentration Sequence Variants

Yan, L., Nicholson, J. A., Bennet, L., Bullock, K., Lombard, M., Smart, H., . . . Greenhalf, W. (2013). Development of a Novel Next Generation Sequencing (NGS) Method for Detection of Low Concentration Sequence Variants. In PANCREAS Vol. 42 (pp. 1390). Retrieved from https://www.webofscience.com/

Conference Paper

Inhibition of Pancreatitis-Associated Cell Death Using a Human Pancreatic Acinar Cell Model

Javed, M. A., Mukherjee, R., Wen, L., Huang, W., Chvanov, M., Awais, M., . . . Sutton, R. (2013). Inhibition of Pancreatitis-Associated Cell Death Using a Human Pancreatic Acinar Cell Model. In PANCREAS Vol. 42 (pp. 1356). Retrieved from https://www.webofscience.com/

Conference Paper

Is the Association of the p.N34S SPINK1 Variant Explicable by a High Risk Haplotype Rather Than the Polymorphism?

Nicholson, J. A., Grant, J., Johnstone, M., Harrison, S., Halloran, C. M., Raraty, M. G. T., . . . Greenhalf, W. (2013). Is the Association of the p.N34S SPINK1 Variant Explicable by a High Risk Haplotype Rather Than the Polymorphism?. In PANCREAS Vol. 42 (pp. 1372). Retrieved from https://www.webofscience.com/

Conference Paper

MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients.

Marshall, E., Romaniuk, C., Ghaneh, P., Wong, H., McKay, M., Chopra, M., . . . Damato, B. E. (2013). MRI in the detection of hepatic metastases from high-risk uveal melanoma: a prospective study in 188 patients.. Br J Ophthalmol, 97, 159-163.

Journal article

Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons from the ESPAC-3 Study

Neoptolemos, J., Valle, J., Palmer, D., Jackson, R., Cox, T., Ghaneh, P., . . . Buechler, M. (2013). Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons from the ESPAC-3 Study. PANCREAS, 42(8), 1372. Retrieved from https://www.webofscience.com/

Journal article

PHASE I TRIAL OF INTRA-ARTERIAL GENE DIRECTED ENZYME PRODRUG THERAPY

Ghaneh, P., Cox, T., & Neoptolemos, J. P. (2013). PHASE I TRIAL OF INTRA-ARTERIAL GENE DIRECTED ENZYME PRODRUG THERAPY. British Journal of Cancer.

Journal article

Pancreatic Cancer hENT1 Expression Predicts Survival from Gemcitabine in Patients from the ESPAC-3 Trial.

Greenhalf, W., Ghaneh, P., Neoptolemos, J., Palmer, D., Cox, T., Lamb, R., . . . Büchler, M. (2013). Pancreatic Cancer hENT1 Expression Predicts Survival from Gemcitabine in Patients from the ESPAC-3 Trial.. Journal of the National Cancer Institute.

Journal article

Review of PET/CT in oncology: is it cost-effective?

Hounsome, B., Edwards, R., Lloyd Williams, H., & Ghaneh, P. (2013). Review of PET/CT in oncology: is it cost-effective?. Journal of Nuclear Medicine.

Journal article

TRO40303 Reduces Mitochondrial Injury and Ameliorates Experimental AP

Javed, M. A., Wen, L., Awais, M., Chvanov, M., Ghaneh, P., Halloran, C., . . . Sutton, R. (2013). TRO40303 Reduces Mitochondrial Injury and Ameliorates Experimental AP. In PANCREAS Vol. 42 (pp. 1356). Retrieved from https://www.webofscience.com/

Conference Paper

Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study

Yip, V. S., Gomez, D., Tan, C. Y., Staettner, S., Terlizzo, M., Fenwick, S., . . . Poston, G. (2013). Tumour size and differentiation predict survival after liver resection for hepatocellular carcinoma arising from non-cirrhotic and non-fibrotic liver: A case-controlled study. In INTERNATIONAL JOURNAL OF SURGERY Vol. 11 (pp. 1078-1082). doi:10.1016/j.ijsu.2013.10.001

DOI
10.1016/j.ijsu.2013.10.001
Conference Paper

2012

The Value of Source Data Verification in a Cancer Clinical Trial

Smith, C. T., Stocken, D. D., Dunn, J., Cox, T., Ghaneh, P., Cunningham, D., & Neoptolemos, J. P. (2012). The Value of Source Data Verification in a Cancer Clinical Trial. PLOS ONE, 7(12). doi:10.1371/journal.pone.0051623

DOI
10.1371/journal.pone.0051623
Journal article

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial

Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., . . . Buechler, M. W. (2012). Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 308(2), 147-156. doi:10.1001/jama.2012.7352

DOI
10.1001/jama.2012.7352
Journal article

Cholecystectomy-related bile duct and vasculobiliary injuries.

Sarno, G., Al-Sarira, A. A., Ghaneh, P., Fenwick, S. W., Malik, H. Z., & Poston, G. J. (2012). Cholecystectomy-related bile duct and vasculobiliary injuries.. The British journal of surgery, 99(8), 1129-1136. doi:10.1002/bjs.8806

DOI
10.1002/bjs.8806
Journal article

Chemotherapy and radiotherapy for pancreatic and periampullary cancer

Halloran, C. M., Ghaneh, P., & Neoptolemos, J. P. (2012). Chemotherapy and radiotherapy for pancreatic and periampullary cancer. In Blumgart's Surgery of the Liver, Pancreas and Biliary Tract (pp. 972-978.e2). Elsevier. doi:10.1016/b978-1-4377-1454-8.00063-1

DOI
10.1016/b978-1-4377-1454-8.00063-1
Chapter

Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases

Jones, R. P., Jackson, R., Dunne, D. F. J., Malik, H. Z., Fenwick, S. W., Poston, G. J., & Ghaneh, P. (2012). Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. BRITISH JOURNAL OF SURGERY, 99(4), 477-486. doi:10.1002/bjs.8667

DOI
10.1002/bjs.8667
Journal article

Microwave ablation of ex vivo human liver and colorectal liver metastases with a novel 14.5 GHz generator

Jones, R. P., Kitteringham, N. R., Terlizzo, M., Hancock, C., Dunne, D., Fenwick, S. W., . . . Malik, H. Z. (2012). Microwave ablation of ex vivo human liver and colorectal liver metastases with a novel 14.5 GHz generator. INTERNATIONAL JOURNAL OF HYPERTHERMIA, 28(1), 43-54. doi:10.3109/02656736.2011.610428

DOI
10.3109/02656736.2011.610428
Journal article

Adjuvant therapy for pancreatic cancer.

Sultana, A., Cox, T., Ghaneh, P., & Neoptolemos, J. P. (2012). Adjuvant therapy for pancreatic cancer.. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 196, 65-88. doi:10.1007/978-3-642-31629-6_5

DOI
10.1007/978-3-642-31629-6_5
Journal article

Cholecystectomy-related bile duct and vasculobiliary injuries

Sarno, G., Al-Sarira, A. A., Ghaneh, P., Fenwick, S. W., Malik, H. Z., & Poston, G. J. (2012). Cholecystectomy-related bile duct and vasculobiliary injuries. British Journal of Surgery, 99, 1129-1136.

Journal article

2011

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

Smith, R. A., Tang, J., Tudur-Smith, C., Neoptolemos, J. P., & Ghaneh, P. (2011). Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. British Journal of cancer, 104, 1140-1151.

Journal article

Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study

Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G. T., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study. PANCREATOLOGY, 11(6), 535-545. doi:10.1159/000333308

DOI
10.1159/000333308
Journal article

Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study

Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology, 11(6), 535-545.

Journal article

2010

Adjuvant therapy in pancreatic cancer.

Thomas, A., Dajani, K., Neoptolemos, J. P., & Ghaneh, P. (2010). Adjuvant therapy in pancreatic cancer.. Digestive diseases (Basel, Switzerland), 28(4-5), 684-692. doi:10.1159/000320099

DOI
10.1159/000320099
Journal article

Minimal Access Retroperitoneal Pancreatic Necrosectomy <i>Improvement in Morbidity and Mortality With a Less Invasive Approach</i>

Raraty, M. G. T., Halloran, C. M., Dodd, S., Ghaneh, P., Connor, S., Evans, J., . . . Neoptolemos, J. P. (2010). Minimal Access Retroperitoneal Pancreatic Necrosectomy <i>Improvement in Morbidity and Mortality With a Less Invasive Approach</i>. ANNALS OF SURGERY, 251(5), 787-793. doi:10.1097/SLA.0b013e3181d96c53

DOI
10.1097/SLA.0b013e3181d96c53
Journal article

A randomized controlled trial of adjuvant chemotherapy using 5-fluorouracil with folinic acid versus gemcitabine and in patients with resectable pancreatic cancer JAMA

Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., . . . European Study Group for Pancreatic Cancer.. (2010). A randomized controlled trial of adjuvant chemotherapy using 5-fluorouracil with folinic acid versus gemcitabine and in patients with resectable pancreatic cancer JAMA. Journal of the American Medical Association, 304, 1073-1081.

Journal article

Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract

Huggett, M. T., Ghaneh, P., & Pereira, S. P. (2010). Drainage and bypass procedures for palliation of malignant diseases of the upper gastrointestinal tract. Clinical Oncology, 22, 755-763.

Journal article

Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach

Raraty, M. G., Halloran, C. M., Dodd, S., Ghaneh, P., Connor, S., Evans, J., . . . Neoptolemos, J. P. (2010). Minimal access retroperitoneal pancreatic necrosectomy: improvement in morbidity and mortality with a less invasive approach. Annals of Surgery, 251, 787-793.

Journal article

2009

Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin

Campbell, F., Smith, R. A., Whelan, P., Sutton, R., Raraty, M., Neoptolemos, J. P., & Ghaneh, P. (2009). Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. HISTOPATHOLOGY, 55(3), 277-283. doi:10.1111/j.1365-2559.2009.03376.x

DOI
10.1111/j.1365-2559.2009.03376.x
Journal article

Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma

Smith, R. A., Bosonnet, L., Raraty, M., Sutton, R., Neoptolemos, J. P., Campbell, F., & Ghaneh, P. (2009). Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. AMERICAN JOURNAL OF SURGERY, 197(4), 466-472. doi:10.1016/j.amjsurg.2007.12.057

DOI
10.1016/j.amjsurg.2007.12.057
Journal article

Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I<SUP>131</SUP> KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma

Sultana, A., Shore, S., Raraty, M. G. T., Vinjamuri, S., Evans, J. E., Smith, C. T., . . . Ghaneh, P. (2009). Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I<SUP>131</SUP> KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma. BMC CANCER, 9. doi:10.1186/1471-2407-9-66

DOI
10.1186/1471-2407-9-66
Journal article

Factors involved in carcinogenesis and prevention in hepatobiliary cancer

Ghaneh, P., Greenhalf, W., & Neoptolemos, J. P. (2009). Factors involved in carcinogenesis and prevention in hepatobiliary cancer. In Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (pp. 421-432).

Chapter

Confounding Effect of Obstructive Jaundice in the Interpretation of Proteomic Plasma Profiling Data for Pancreatic Cancer

Yan, L., Tonack, S., Smith, R., Dodd, S., Jenkins, R. E., Kitteringham, N., . . . Costello, E. (2009). Confounding Effect of Obstructive Jaundice in the Interpretation of Proteomic Plasma Profiling Data for Pancreatic Cancer. JOURNAL OF PROTEOME RESEARCH, 8(1), 142-148. doi:10.1021/pr800451h

DOI
10.1021/pr800451h
Journal article

'Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma'

Smith, R. A., Bosonnet, L., Raraty, M., Sutton, R., Neoptolemos, J. P., Campbell, F., & Ghaneh, P. (2009). 'Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma'. American Journal of Surgery, 167, 466-472.

Journal article

A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.

Sakka, N., Smith, R. A., Whelan, P., Ghaneh, P., Sutton, R., Raraty, M., . . . Neoptolemos, J. P. (2009). A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 9(5), 670-676. doi:10.1159/000181179

DOI
10.1159/000181179
Journal article

A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.

Sakka, N., Smith, R., Whelan, P., Ghaneh, P., Sutton, R., Raraty, M., . . . Neoptolemos, J. P. (2009). A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours.. Pancreatology, 9, 670-676.

Journal article

Longitudinal Quality of Life Data can provide Insights on the Impact of Adjuvant Treatment for Pancreatic Cancer - Subset Analysis of the ESPAC-1 Data

Carter, R., Stocken, D. D., Bramhall, S., Olah, A., Kelemen, D., Bassi, C., . . . Neoptolemos, J. P. (2009). Longitudinal Quality of Life Data can provide Insights on the Impact of Adjuvant Treatment for Pancreatic Cancer - Subset Analysis of the ESPAC-1 Data. International Journal of Cancer, 124, 2960-2965.

Journal article

Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure

de Liguori Carino, N., O'Reilly, D. A., Dajani, K., Ghaneh, P., Poston, G. J., & Wu, A. V. (2009). Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure. European Journal of Surgical Oncology, 35, 957-962.

Journal article

Randomised Phase I/II trial assessing the safety and efficacy of radio labelled anti-carcinoembryonic antigen antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma

Sultana, A., Shore, S., Vinjamuri, S., Evans, J. C., Tudur Smith, C., Chauhan, S., . . . Ghaneh, P. (2009). Randomised Phase I/II trial assessing the safety and efficacy of radio labelled anti-carcinoembryonic antigen antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma. BMC cancer, 9, 66.

Journal article

The confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer

Yan, L., Tonack, S., Smith, R., Dodd, S., Jenkins, R., Kitteringham, N., . . . Costello, E. (2009). The confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer. Journal of Proteome Research, 8, 142-148.

Journal article

2008

Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps.

Al-Sarireh, B., Ghaneh, P., Gardner-Thorpe, J., Raraty, M., Hartley, M., Sutton, R., & Neoptolemos, J. P. (2008). Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps.. The British journal of surgery, 95(12), 1506-1511. doi:10.1002/bjs.6412

DOI
10.1002/bjs.6412
Journal article

Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.

Smith, R. A., Dajani, K., Dodd, S., Whelan, P., Raraty, M., Sutton, R., . . . Ghaneh, P. (2008). Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.. Annals of surgical oncology, 15(11), 3138-3146. doi:10.1245/s10434-008-0148-z

DOI
10.1245/s10434-008-0148-z
Journal article

New treatment options for advanced pancreatic cancer.

Middleton, G., Ghaneh, P., Costello, E., Greenhalf, W., & Neoptolemos, J. P. (2008). New treatment options for advanced pancreatic cancer.. Expert review of gastroenterology & hepatology, 2(5), 673-696. doi:10.1586/17474124.2.5.673

DOI
10.1586/17474124.2.5.673
Journal article

Biology and management of pancreatic cancer

Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2007). Biology and management of pancreatic cancer. GUT, 56(8), 1134-1152. doi:10.1136/gut.2006.103333

DOI
10.1136/gut.2006.103333
Journal article

Liver resection for colorectal liver metastases in older patients.

de Liguori Carino, N., van Leeuwen, B. L., Ghaneh, P., Wu, A., Audisio, R. A., & Poston, G. J. (2008). Liver resection for colorectal liver metastases in older patients.. Critical reviews in oncology/hematology, 67(3), 273-278. doi:10.1016/j.critrevonc.2008.05.003

DOI
10.1016/j.critrevonc.2008.05.003
Journal article

Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma

Smith, R. A., Bosonnet, L., Ghaneh, P., Raraty, M., Sutton, R., Campbell, F., & Neoptolemos, J. P. (2008). Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. DIGESTIVE SURGERY, 25(3), 226-232. doi:10.1159/000140961

DOI
10.1159/000140961
Journal article

Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio

Smith, R. A., Ghaneh, P., Sutton, R., Raraty, M., Campbell, F., & Neoptolemos, J. P. (2008). Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. JOURNAL OF GASTROINTESTINAL SURGERY, 12(8), 1422-1428. doi:10.1007/s11605-008-0554-3

DOI
10.1007/s11605-008-0554-3
Journal article

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison

Sultana, A., Ghaneh, P., Cunningham, D., Starling, N., Neoptolemos, J. P., & Smith, C. T. (2008). Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison. BMC CANCER, 8. doi:10.1186/1471-2407-8-192

DOI
10.1186/1471-2407-8-192
Journal article

The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer

Smith, R. A., Bosonnet, L., Ghaneh, P., Sutton, R., Evans, J., Healey, P., . . . Neoptolemos, J. P. (2008). The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. SURGERY, 143(5), 658-666. doi:10.1016/j.surg.2007.12.014

DOI
10.1016/j.surg.2007.12.014
Journal article

Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

Halloran, C. M., Ghaneh, P., Connor, S., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. T. (2008). Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. BRITISH JOURNAL OF SURGERY, 95(4), 453-459. doi:10.1002/bjs.6043

DOI
10.1002/bjs.6043
Journal article

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Ghaneh, P., Smith, R., Tudor-Smith, C., Raraty, M., & Neoptolemos, J. P. (2008). Neoadjuvant and adjuvant strategies for pancreatic cancer.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 34(3), 297-305. doi:10.1016/j.ejso.2007.07.204

DOI
10.1016/j.ejso.2007.07.204
Journal article

Direct activation of cytosolic Ca<SUP>2+</SUP> signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells

Murphy, J. A., Criddle, D. N., Sherwood, M., Chvanov, M., Mukherjee, R., McLaughlin, E., . . . Sutton, R. (2008). Direct activation of cytosolic Ca<SUP>2+</SUP> signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. GASTROENTEROLOGY, 135(2), 632-641. doi:10.1053/j.gastro.2008.05.026

DOI
10.1053/j.gastro.2008.05.026
Journal article

Gemcitabine-Based Combination Chemotherapy in the Treatment of Advanced Pancreatic Cancer

Sultana, A., Neoptolemos, J. P., Frauscher, F., & Ghaneh, P. (2008). Gemcitabine-Based Combination Chemotherapy in the Treatment of Advanced Pancreatic Cancer. American Journal of Hematology and Oncology, 7, 96-100.

Journal article

2007

Adjuvant chemotherapy—the standard after resection for pancreatic cancer

Ghaneh, P., & Neoptolemos, J. (2007). Adjuvant chemotherapy—the standard after resection for pancreatic cancer. The American Journal of Surgery, 194(4), S131-S137. doi:10.1016/j.amjsurg.2007.05.021

DOI
10.1016/j.amjsurg.2007.05.021
Journal article

Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts

Saraga, G., Mafficini, A., Ghaneh, P., Sorio, C., & Costello, E. (2007). Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts. CANCER GENE THERAPY, 14(9), 781-790. doi:10.1038/sj.cgt.7701066

DOI
10.1038/sj.cgt.7701066
Journal article

A new approach to managing intraductal papillary mucinous pancreatic neoplasms.

Ghaneh, P., & Neoptolemos, J. (2007). A new approach to managing intraductal papillary mucinous pancreatic neoplasms.. Gut, 56(8), 1041-1044. doi:10.1136/gut.2006.113068

DOI
10.1136/gut.2006.113068
Journal article

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer

Sultana, A., Smith, C. T., Cunningham, D., Starling, N., Neoptolemos, J. P., & Ghaneh, P. (2007). Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. JOURNAL OF CLINICAL ONCOLOGY, 25(18), 2607-2615. doi:10.1200/JCO.2006.09.2551

DOI
10.1200/JCO.2006.09.2551
Journal article

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.

Sultana, A., Tudur Smith, C., Cunningham, D., Starling, N., Tait, D., Neoptolemos, J. P., & Ghaneh, P. (2007). Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy.. British journal of cancer, 96(8), 1183-1190. doi:10.1038/sj.bjc.6603719

DOI
10.1038/sj.bjc.6603719
Journal article

COMPLICATIONS OF PANCREATIC SURGERY

Alexakis, N., Connor, S., Ghaneh, P., Sutton, R., Evans, J. C., & Neoptolemos, J. P. (2007). COMPLICATIONS OF PANCREATIC SURGERY. In Surgical Complications (pp. 421-466). PUBLISHED BY IMPERIAL COLLEGE PRESS AND DISTRIBUTED BY WORLD SCIENTIFIC PUBLISHING CO.. doi:10.1142/9781860948329_0013

DOI
10.1142/9781860948329_0013
Chapter

Comment on "Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal"

Ghaneh, P., Tudur-Smith, C., & Neoptolemos, J. P. (2007). Comment on "Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal". DRUGS, 67(17), 2487-2490. doi:10.2165/00003495-200767170-00002

DOI
10.2165/00003495-200767170-00002
Journal article

Complications of pancreatic surgery

Alexakis, N., Connor, S., Ghaneh, P., Sutton, R., Evans, J. C., & Neoptolemos, J. P. (2007). Complications of pancreatic surgery. In N. S. Hakim, & V. E. Papalois (Eds.), Surgical complications: diagnosis and treatment (pp. xxx). London: Imperial College Press.

Chapter

Epidemiology of pancreatic cancer

Alexakis, N., Ghaneh, P., & Neoptolemos, J. P. (2007). Epidemiology of pancreatic cancer. In H. G. Beger, M. Buchler, R. Kozarek, M. Lerch, J. Neoptolemos, A. Warshaw, . . . K. Shiratori (Eds.), The Pancreas (pp. ??). Eastbourne: Blackwell.

Chapter

Factors involved in carcinogenesis and prevention in hepatobiliarycancer

Ghaneh, P., Greenhalf, W., & Neoptolemos, J. P. (2007). Factors involved in carcinogenesis and prevention in hepatobiliarycancer. In J. Jankowski, R. E. Sampliner, D. Kerr, & Y. Fong (Eds.), Structure of GI Oncology: A Critical MDT Approach (pp. ??). Oxford: Blackwell Publishing.

Chapter

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Ghaneh, P., Smith, R., Tudor-Smith, C., Raraty, M., & Neoptolemos, J. P. (2007). Neoadjuvant and adjuvant strategies for pancreatic cancer.. European Journal of Surgical Oncology. Retrieved from http://www.sciencedirect.com/

Journal article

When is pancreatitis considered to be of biliary origin and what are the implications for management?

Alexakis, N., Lombard, M., Raraty, M., Ghaneh, P., Smart, H. L., Gilmore, I., . . . Neoptolemos, J. P. (2007). When is pancreatitis considered to be of biliary origin and what are the implications for management?. PANCREATOLOGY, 7(2-3), 131-141. doi:10.1159/000104238

DOI
10.1159/000104238
Journal article

2006

The case for adjuvant chemotherapy in pancreatic cancer.

Ghaneh, P., Sultana, A., Shore, S., Stocken, D., & Neoptolemos, J. (2006). The case for adjuvant chemotherapy in pancreatic cancer.. Best practice & research. Clinical gastroenterology, 20(2), 383-401. doi:10.1016/j.bpg.2005.11.008

DOI
10.1016/j.bpg.2005.11.008
Journal article

The inherited genetics of pancreatic cancer and prospects for secondary screening.

Vitone, L. J., Greenhalf, W., McFaul, C. D., Ghaneh, P., & Neoptolemos, J. P. (2006). The inherited genetics of pancreatic cancer and prospects for secondary screening.. Best practice & research. Clinical gastroenterology, 20(2), 253-283. doi:10.1016/j.bpg.2005.10.007

DOI
10.1016/j.bpg.2005.10.007
Journal article

Cancer Stats

Ghaneh, P., & Neoptolemos, J. P. (2006). Cancer Stats. London: Cancer Research UK.

Report

Trattamento miniinvasivo della pancreatite acuta necrotizzante.

Raraty, M. G. T., Connor, S., Evans, J., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2006). Trattamento miniinvasivo della pancreatite acuta necrotizzante.. In S. Pedrazzoli (Ed.), Nuovo Trattato di Tecnica Chirurgica Pancreas - Peritoneo - Retroperitoneo - Surrene - Milza (pp. 183-187). Milano: UTET.

Chapter

2005

Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer.

Lytras, D., Connor, S., Bosonnet, L., Jayan, R., Evans, J., Hughes, M., . . . Neoptolemos, J. P. (2005). Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer.. Digestive surgery, 22(1-2), 55-62. doi:10.1159/000085347

DOI
10.1159/000085347
Journal article

Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy

Connor, S., Bosonnet, L., Alexakis, N., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2005). Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy. DIGESTIVE SURGERY, 22(1-2), 80-85. doi:10.1159/000085297

DOI
10.1159/000085297
Journal article

Adjuvant and neoadjuvant treatment of resectable pancreatic cancer: what is worth attempting?

Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2005). Adjuvant and neoadjuvant treatment of resectable pancreatic cancer: what is worth attempting?. In J. E. Dominguez-Munoz (Ed.), Clinical Pancreatology for practising gastroenterologists and surgeons (pp. 444-454). Malden, Massachusetts: Blackwell.

Chapter

Adjuvant therapy of pancreatic cancer

Ghaneh, P., & Neoptolemos, J. P. (2005). Adjuvant therapy of pancreatic cancer. In E. al (Ed.), Exocrine Pancreatic Cancer. The European Pancreatic Cancer- Research Cooperative (EPC-RC) (pp. 364-381). Hannover: Felsenstein CCCP.

Chapter

Early and late complications after pancreatic necrosectomy

Connor, S., Alexakis, N., Raraty, M. G. T., Ghaneh, P., Evans, J., Hughes, M., . . . Neoptolemos, J. P. (2005). Early and late complications after pancreatic necrosectomy. SURGERY, 137(5), 499-505. doi:10.1016/j.surg.2005.01.003

DOI
10.1016/j.surg.2005.01.003
Journal article

Hepatic Metastases

Hugh, T. J., Ghaneh, P., & Poston, G. J. (2005). Hepatic Metastases. In O. J. Garden (Ed.), A Companion Series in Surgical Practice: Hepatobiliary and Pancreatic Surgery. (pp. 97-130). Philadelphia: Elsevier Saunders Ltd.

Chapter

Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.

Bassi, C., Stocken, D. D., Olah, A., Friess, H., Buckels, J., Hickey, H., . . . European Study Group for Pancreatic Cancer (ESPAC). (2005). Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.. Digestive surgery, 22(5), 353-363. doi:10.1159/000089771

DOI
10.1159/000089771
Journal article

Pancreatic Exocrine Tumors

Ghaneh, P., & Neoptolemos, J. P. (2005). Pancreatic Exocrine Tumors. In W. M. Weinstein, C. J. Hawkey, & J. Bosch (Eds.), Clinical Gastroenterology and Hepatology. (pp. 521-534). Edinburgh: Elsevier Limited.

Chapter

Pancreatic exocrine tumours

Ghaneh, P., & Neoptolemos, J. P. (2005). Pancreatic exocrine tumours. In W. M. Weinstein, C. J. Hawkey, & J. Bosch (Eds.), Clinical Gastroenterology and Hepatology (pp. 521-533). London: Elsevier Mosby.

Chapter

Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer

Lytras, D., Connor, S., Bosonnet, L., Jayan, R., Evans, J., Hughes, M., . . . Neoptolemos, J. P. (2005). Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. DIGESTIVE SURGERY, 22(1-2), 55-61. doi:10.1159/000085347

DOI
10.1159/000085347
Journal article

SURGERY IN THE TREATMENT OF ACUTE PANCREATITIS - MINIMAL ACCESS PANCREATIC NECROSECTOMY

Connor, S., Raraty, M. G. T., Howes, N., Evans, J., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2005). SURGERY IN THE TREATMENT OF ACUTE PANCREATITIS - MINIMAL ACCESS PANCREATIC NECROSECTOMY. SCANDINAVIAN JOURNAL OF SURGERY, 94(2), 135-142. doi:10.1177/145749690509400210

DOI
10.1177/145749690509400210
Journal article

Trials of gene therapy for pancreatic carcinoma.

Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma.. Current gastroenterology reports, 7(3), 165-169. doi:10.1007/s11894-005-0028-7

DOI
10.1007/s11894-005-0028-7
Journal article

Trials of gene therapy for pancreatic carcinoma.

Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma.. Curr Gastroenterol Rep, 7, 165-169.

Journal article

2004

Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status

Connor, S., Bosonnet, L., Ghaneh, P., Alexakis, N., Hartley, M., Campbell, F., . . . Neoptolemos, J. P. (2004). Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status. BRITISH JOURNAL OF SURGERY, 91(12), 1592-1599. doi:10.1002/bjs.4761

DOI
10.1002/bjs.4761
Journal article

Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis

Connor, S., Alexakis, N., Neal, T., Raraty, M., Ghaneh, P., Evans, J., . . . Neoptolemos, J. P. (2004). Fungal infection but not type of bacterial infection is associated with a high mortality in primary and secondary infected pancreatic necrosis. DIGESTIVE SURGERY, 21(4), 297-304. doi:10.1159/000080884

DOI
10.1159/000080884
Journal article

Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours

Doran, H. E., Bosonnet, L., Connor, S., Jones, L., Garvey, C., Hughes, M., . . . Sutton, R. (2004). Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours. DIGESTIVE SURGERY, 21(4), 305-313. doi:10.1159/000080885

DOI
10.1159/000080885
Journal article

Current standards of surgery for pancreatic cancer

Alexakis, N., Halloran, C., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004). Current standards of surgery for pancreatic cancer. BRITISH JOURNAL OF SURGERY, 91(11), 1410-1427. doi:10.1002/bjs.4794

DOI
10.1002/bjs.4794
Journal article

Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis

Alexakis, N., Connor, S., Ghaneh, P., Raraty, M., Lombard, M., Smart, H., . . . Neoptolemos, J. P. (2004). Influence of opioid use on surgical and long-term outcome after resection for chronic pancreatitis. SURGERY, 136(3), 600-608. doi:10.1016/j.surg.2004.02.011

DOI
10.1016/j.surg.2004.02.011
Journal article

Major resection for chronic pancreatitis in patients with vascular involvement is associated with increased postoperative mortality

Alexakis, N., Sutton, R., Raraty, M., Connor, S., Ghaneh, P., Hughes, M. L., . . . Neoptolemos, J. P. (2004). Major resection for chronic pancreatitis in patients with vascular involvement is associated with increased postoperative mortality. BRITISH JOURNAL OF SURGERY, 91(8), 1020-1026. doi:10.1002/bjs.4616

DOI
10.1002/bjs.4616
Journal article

5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16<SUP>INK4A</SUP> greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells

Halloran, C. M., Ghaneh, P., Shore, S., Greenhalf, W., Zumstein, L., Wilson, D., . . . Costello, E. (2004). 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16<SUP>INK4A</SUP> greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. JOURNAL OF GENE MEDICINE, 6(5), 514-525. doi:10.1002/jgm.540

DOI
10.1002/jgm.540
Journal article

Cancer in the elderly: pancreatic cancer

Shore, S., Vimalachandran, D., Raraty, M. G. T., & Ghaneh, P. (2004). Cancer in the elderly: pancreatic cancer. SURGICAL ONCOLOGY-OXFORD, 13(4), 201-210. doi:10.1016/j.suronc.2004.11.001

DOI
10.1016/j.suronc.2004.11.001
Journal article

Diagnosis, treatment and outcome of pancreatoblastoma

Dhebri, A. R., Connor, S., Campbell, F., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004). Diagnosis, treatment and outcome of pancreatoblastoma. PANCREATOLOGY, 4(5), 441-451. doi:10.1159/000079823

DOI
10.1159/000079823
Journal article

Genetics and prevention of pancreatic cancer.

Vimalachandran, D., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2004). Genetics and prevention of pancreatic cancer.. Cancer control : journal of the Moffitt Cancer Center, 11(1), 6-14. doi:10.1177/107327480401100102

DOI
10.1177/107327480401100102
Journal article

Hereditary pancreatic endocrine tumours

Alexakis, N., Connor, S., Ghaneh, P., Lombard, M., Smart, H. L., Evans, J., . . . Neoptolemos, J. P. (2004). Hereditary pancreatic endocrine tumours. PANCREATOLOGY, 4(5), 417-433. doi:10.1159/000079616

DOI
10.1159/000079616
Journal article

2003

Surgery for midgut carcinoid

Sutton, R., Doran, H. E., Williams, E. M. I., Vora, J., Vinjamuri, S., Evans, J., . . . Neoptolemos, J. P. (2003). Surgery for midgut carcinoid. ENDOCRINE-RELATED CANCER, 10(4), 469-481. doi:10.1677/erc.0.0100469

DOI
10.1677/erc.0.0100469
Journal article

Increasing age and APACHE II scores are the main determinants of outcome from pancreatic necrosectomy

Connor, S., Ghaneh, P., Raraty, M., Rosso, E., Hartley, M. N., Garvey, C., . . . Neoptolemos, J. P. (2003). Increasing age and APACHE II scores are the main determinants of outcome from pancreatic necrosectomy. BRITISH JOURNAL OF SURGERY, 90(12), 1542-1548. doi:10.1002/bjs.4341

DOI
10.1002/bjs.4341
Journal article

Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis

Alexakis, N., Ghaneh, P., Connor, S., Raraty, M., Sutton, R., & Neoptolemos, J. P. (2003). Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis. BRITISH JOURNAL OF SURGERY, 90(11), 1401-1408. doi:10.1002/bjs.4324

DOI
10.1002/bjs.4324
Journal article

Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment.

Rosso, E., Alexakis, N., Ghaneh, P., Lombard, M., Smart, H. L., Evans, J., & Neoptolemos, J. P. (2003). Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment.. Digestive surgery, 20(5), 397-406. doi:10.1159/000072706

DOI
10.1159/000072706
Journal article

Minimally invasive retroperitoneal pancreatic necrosectomy

Connor, S., Ghaneh, P., Raraty, M., Sutton, R., Rosso, E., Garvey, C. J., . . . Neoptolemos, J. P. (2003). Minimally invasive retroperitoneal pancreatic necrosectomy. DIGESTIVE SURGERY, 20(4), 270-277. doi:10.1159/000071184

DOI
10.1159/000071184
Journal article

[Adjuvant and additive therapy for cancer of the pancreas].

Neoptolemos, J. P., Raraty, M. G. T., Ghaneh, P., Hickey, H., Stocken, D. D., Dunn, J. A., . . . Büchler, M. W. (2003). [Adjuvant and additive therapy for cancer of the pancreas].. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 74(3), 191-201. doi:10.1007/s00104-003-0614-x

DOI
10.1007/s00104-003-0614-x
Journal article

Review article: Chemotherapy for pancreatic cancer

Shore, S., Raraty, M. G. T., Ghaneh, P., & Neoptolemos, J. P. (2003). Review article: Chemotherapy for pancreatic cancer. Alimentary Pharmacology and Therapeutics, 18(11-12), 1049-1069. doi:10.1046/j.1365-2036.2003.01781.x

DOI
10.1046/j.1365-2036.2003.01781.x
Journal article

2002

Complications of pancreatic cancer resection

Halloran, C. M., Ghaneh, P., Bosonnet, L., Hartley, M. N., Sutton, R., & Neoptolemos, J. P. (2002). Complications of pancreatic cancer resection. DIGESTIVE SURGERY, 19(2), 138-146. doi:10.1159/000052029

DOI
10.1159/000052029
Journal article

The role of adjuvant therapy for pancreatic cancer.

Magee, C. J., Ghaneh, P., Hartley, M., Sutton, R., & Neoptolemos, J. P. (2002). The role of adjuvant therapy for pancreatic cancer.. Expert opinion on investigational drugs, 11(1), 87-107. doi:10.1517/13543784.11.1.87

DOI
10.1517/13543784.11.1.87
Journal article

Adjuvant Chemotherapy for Pancreatic Cancer

Raraty, M. G. T., Magee, C. J., Ghaneh, P., & Neoptolemos, J. P. (2002). Adjuvant Chemotherapy for Pancreatic Cancer. In J. Permert, M. Herrington, & T. Adrian (Eds.), Controversies in Pancreatology (pp. 226-242). Stockholm: Carlsson Communication.

Chapter

New techniques and agents in the adjuvant therapy of pancreatic cancer.

Raraty, M. G. T., Magee, C. J., Ghaneh, P., & Neoptolemos, J. P. (2002). New techniques and agents in the adjuvant therapy of pancreatic cancer.. Acta Oncologica, 41(7-8), 582-595.

Journal article

2001

Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.

Magee, C. J., Greenhalf, W., Howes, N., Ghaneh, P., & Neoptolemos, J. P. (2001). Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications.. Surgical oncology, 10(1-2), 1-23. doi:10.1016/s0960-7404(01)00016-0

DOI
10.1016/s0960-7404(01)00016-0
Journal article

Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.

Humphreys, M. J., Ghaneh, P., Greenhalf, W., Campbell, F., Clayton, T. M., Everett, P., . . . Neoptolemos, J. P. (2001). Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases.. Gene therapy, 8(16), 1241-1247. doi:10.1038/sj.gt.3301518

DOI
10.1038/sj.gt.3301518
Journal article

Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.

Ghaneh, P., Greenhalf, W., Humphreys, M., Wilson, D., Zumstein, L., Lemoine, N. R., & Neoptolemos, J. P. (2001). Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo.. Gene therapy, 8(3), 199-208. doi:10.1038/sj.gt.3301394

DOI
10.1038/sj.gt.3301394
Journal article

Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo

Ghaneh, P., Greenhalf, W., Humphreys, M., Wilson, D., Zumstein, L., Lemoine, N. R., & Neoptolemos, J. P. (2001). Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo. Gene Therapy, 8(3), 199-208. doi:10.1038/sj.gt.3301394

DOI
10.1038/sj.gt.3301394
Journal article

Management of necrotizing pancreatitis.

Slavin, J., Ghaneh, P., Sutton, R., Hartley, M., Rowlands, P., Garvey, C., . . . Neoptolemos, J. (2001). Management of necrotizing pancreatitis.. World journal of gastroenterology, 7(4), 476-481. doi:10.3748/wjg.v7.i4.476

DOI
10.3748/wjg.v7.i4.476
Journal article

2000

Adjuvant therapy for pancreatic cancer.

Ghaneh, P., Slavin, J., Sutton, R., & Neoptolemos, J. P. (2000). Adjuvant therapy for pancreatic cancer.. Swiss surgery = Schweizer Chirurgie = Chirurgie suisse = Chirurgia svizzera, 6(5), 289-295. doi:10.1024/1023-9332.6.5.289

DOI
10.1024/1023-9332.6.5.289
Journal article

Gene therapy for pancreatic cancer - current and prospective strategies

Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000). Gene therapy for pancreatic cancer - current and prospective strategies. SURGICAL ONCOLOGY-OXFORD, 9(4), 181-191. doi:10.1016/S0960-7404(01)00011-1

DOI
10.1016/S0960-7404(01)00011-1
Journal article

Pylorus-preserving Kausch-Whipple resection: the successor of the classical Kausch-Whipple in chronic pancreatitis.

Slavin, J., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2000). Pylorus-preserving Kausch-Whipple resection: the successor of the classical Kausch-Whipple in chronic pancreatitis.. Annali italiani di chirurgia, 71(1), 57-64.

Journal article

1999

Pancreatic disease: recent advances

Sutton, R., Slavin, J. P., Ghaneh, P., & Neoptolemos, J. P. (1999). Pancreatic disease: recent advances. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 11(1), 33-36. doi:10.1097/00042737-199901000-00007

DOI
10.1097/00042737-199901000-00007
Journal article

The future of surgery for pancreatic cancer.

Slavin, J., Ghaneh, P., Jones, L., Sutton, R., Hartley, M., & Neoptolemos, J. P. (1999). The future of surgery for pancreatic cancer.. Annals of oncology : official journal of the European Society for Medical Oncology, 10 Suppl 4, 285-290. doi:10.1023/a:1008349406118

DOI
10.1023/a:1008349406118
Journal article

The potential for gene therapy in pancreatic cancer.

Humphreys, M. J., Greenhalf, W., Neoptolemos, J. P., & Ghaneh, P. (1999). The potential for gene therapy in pancreatic cancer.. International journal of pancreatology : official journal of the International Association of Pancreatology, 26(1), 5-21. doi:10.1385/ijgc:26:1:5

DOI
10.1385/ijgc:26:1:5
Journal article